Physician

Rona Beth Holmes, MD

According to 2025 Medicare claims, Rona Holmes, MD (NPI: 1316974090) practices dermatology in the Auburn-Opelika, AL market, with the plurality of this provider's patient population coming from Lee, AL. This provider's primary affiliated billing organization is AUBURN DERMATOLOGY AND SKIN CANCER CENTER (NPI: 1215029053) and primary practice location at 36830-8447.

Holmes' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 620 traditional Medicare patients, billed 4,200 HCPCS/CPT codes, and received $128,304 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,351 prescription claims across 500 beneficiaries totaling $804,142 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 46 records totaling $1,480. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $345,955 to $128,304. In contrast, Part D prescription costs have moved sharply higher in recent years, from $180,232 to $804,142. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$173K$346K2015 Medicare payment: $345,955 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $345,411 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $255,681 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $205,796 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $209,653 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $165,183 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $200,059 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $174,266 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $164,728 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $128,304 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,56410,642$345,955
20161,57310,405$345,411
20171,0597,733$255,681
20189478,117$205,796
20199037,677$209,653
20207945,564$165,183
20217665,328$200,059
20226976,500$174,266
20236815,114$164,728
20246204,200$128,304

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$402K$804K2015 Drug cost: $180,232 (USD; Tot_Drug_Cst)2016 Drug cost: $203,643 (USD; Tot_Drug_Cst)2017 Drug cost: $207,175 (USD; Tot_Drug_Cst)2018 Drug cost: $179,621 (USD; Tot_Drug_Cst)2019 Drug cost: $197,301 (USD; Tot_Drug_Cst)2020 Drug cost: $164,865 (USD; Tot_Drug_Cst)2021 Drug cost: $220,265 (USD; Tot_Drug_Cst)2022 Drug cost: $706,325 (USD; Tot_Drug_Cst)2023 Drug cost: $719,545 (USD; Tot_Drug_Cst)2024 Drug cost: $804,142 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154751,351$180,232
20164231,180$203,643
20174261,285$207,175
20184401,189$179,621
20194121,122$197,301
20203931,144$164,865
20214501,292$220,265
20224661,313$706,325
20234681,340$719,545
20245001,351$804,142

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more270369$72
11102Biopsy of related skin growth, first growth254329$50
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more400533$48
17000Destruction of precancer skin growth, 1 growth255375$28
17003Destruction of precancer skin growth, 2-14 growths1741,092$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa302,464$622,179
OtezlaApremilast14420$68,382
Dupixent PenDupilumab14392$53,692
FluocinonideFluocinonide1113,226$5,190
MetronidazoleMetronidazole591,709$3,834

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.46$1,480ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Rona Beth Holmes, MD?

Tedicare shows public-source Medicare data for Rona Beth Holmes, MD (NPI 1316974090), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rona Beth Holmes, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rona Beth Holmes, MD?

Rona Beth Holmes, MD is linked to AUBURN DERMATOLOGY AND SKIN CANCER CENTER (billing NPI 1215029053) in the available physician profile data.

Does Rona Beth Holmes, MD have Open Payments data?

Rona Beth Holmes, MD has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.